Aquestive Therapeutics, Inc. (AQST) — DEF 14A Filings
All DEF 14A filings from Aquestive Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Aquestive Therapeutics Files Proxy Statement for 2025 Annual Meeting
— Apr 25, 2025 Risk: low
Aquestive Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 25, 2025, for its annual meeting on June 11, 2025. The filing concerns the -
Aquestive Therapeutics Announces 2024 Annual Meeting of Stockholders
— Apr 26, 2024 Risk: low
Aquestive Therapeutics, Inc. (AQST) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. The 2024 Annual Meeting of Stockholders for Aquestive Ther
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX